Intersect ENT, Inc.

Intersect ENT, Inc.

Intersect ENT, Inc.

Overview
Date Founded

2003

Headquarters

1555 Adams Drive,Menlo Park, CA 94025

Type of Company

Public

Employees (Worldwide)

402

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Medical Products & Equipment

Company Description

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

Contact Data
Trying to get in touch with decision makers at Intersect ENT, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Chief Financial Officer & Executive Vice President

Chief Operating Officer

Chief People Officer

Vice President, Regulatory Affairs

Vice President, Global Market Access

Vice President, Healthcare Economics & Reimbursement

Owner

Head-Media Relations

Director Research & Development

Paths to Intersect ENT, Inc.
Potential Connections via
Relationship Science
You
Intersect ENT, Inc.
Owners & Shareholders
Details Hidden

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment and philanthropy—all toward the end goal of cures for disease, improved quality of life and reduced cost of care. As of late 2019, the firm manages nearly $10 billion in assets. Providing value beyond capital, Deerfield generally maintains a combined portfolio of more than 200 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company. Having many years of operational expertise, Deerfielders are highly engaged and adept at navigating the complex crosscurrents ever-present in the healthcare and financial industries. Collaboration, intellectual curiosity and pragmatism drive Deerfield’s approach. With its holistic view, Deerfield tailors flexible financing options designed to meet the needs of entrepreneurs and corporate partners.

Details Hidden

First Light Asset Management manages a long-only health care equity investment strategy (the Genesis Strategy) for separate account clients. The Genesis Strategy utilizes a fundamental, bottom-up approach to stock selection in an attempt to primarily seek out high quality, reasonably priced, growth-equity opportunities among publicly-traded micro to small/mid-cap health care and life sciences companies. It targets companies developing transformative devices, technologies and innovations that may save money and/or improve patient care.

Details Hidden

Pura Vida Investments focuses on long/short equity investments in the healthcare and wellness sectors.

Recent Transactions
Details Hidden

Intersect ENT, Inc. issued USD Common Stock

Details Hidden

Intersect ENT, Inc. issued USD Common Stock

Details Hidden

Intersect ENT, Inc. raised money in a private placement transaction

Transaction Advisors
Underwriter

Advised onIntersect ENT, Inc. issued USD Common Stock

Underwriter

Advised onIntersect ENT, Inc. issued USD Common Stock

Underwriter

Advised onIntersect ENT, Inc. issued USD Common Stock

Associate

Advised onIntersect ENT, Inc. issued USD Common Stock

Co-Chair, Tax Practice Group

Advised onIntersect ENT, Inc. issued USD Common Stock

Associate

Advised onIntersect ENT, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Assurance Partner at Ernst & Young LLP

Clients

TO PROVIDE PATIENT CARE AT THE HIGHEST QUALITY, MOST TECHNOLOGICALLY ADVANCED AND CONSISTENT MULTIDISCIPLINARY CARE.

Key Stats and Financials As of 2019
Market Capitalization
$538M
Total Enterprise Value
$703M
Earnings Per Share
$-1.37
Revenue
$109M
Net Profit
$-43M
EBITDA
$-41.5M
EBITDAMargin
-38.02%
Total Debt
$12.2M
Total Equity
$118M
Enterprise Value / Sales
6.44x
TEVNet Income
-16.35x
Debt TEV
0.02x
Three Year Compounded Annual Growth Rate Of Revenue
11.51%
Investors
Details Hidden

Medtronic was founded in 1949 as a medical equipment repair shop by Earl Bakken and his brother-in-law, Palmer Hermundslie. Since then, we've grown into a multinational company that uses technology to transform the way debilitating, chronic diseases are treated.Our first life-changing therapy – a wearable, battery-powered cardiac pacemaker – was the foundation for dozens more Medtronic therapies that use our electrical stimulation expertise to improve the lives of millions of people. Over the years, we adapted additional technologies for the human body, including radio frequency therapies, mechanical devices, drug and biologic delivery devices, and diagnostic tools. Today, our technologies are used to treat more than 30 chronic diseases affecting many areas of the body.

Details Hidden

Kleiner Perkins Caufield & Byers (KPCB) focuses on investments in the life sciences, biodefense, green technology, information technology and companies with new technologies related to the iPhone and iPod touchpad platform.The firm's information technology investments focus on the consumer, enterprise, semiconductors, security and communications industries. They invest primarily in early-stage ventures that are incubating new companies with proven entrepreneurs and good ideas.KPCB's life sciences investments include medical devices, drugs, vaccines, personalized medicine, diagnostics and healthcare information technology and services. Their pandemic and biodefense investment initiative focuses on investments in companies with innovations in disease surveillance, rapid diagnostics, new vaccine technology, portable and less expensive manufacturing of vaccines and new antiviral drugs.The firm's iFund invests in market-changing ideas and products that extend the iPhone and iPod touch platform. The Fund invests across all sizes and stages. KPCB targets investments in companies that are developing applications, services and components. Their specific areas of interest include: location-based services, social networking, eCommerce (including advertising and payments), communication and entertainment.

Details Hidden

Harmony Partners is a bi-coastal boutique venture capital firm whose mission is to enable software entrepreneurs to optimize expansion stage financings. With offices in New York City and Silicon Valley, Harmony fills a gap in the market for entrepreneur-friendly expansion stage capital. Harmony eliminates the deal constraints of traditional growth equity firms: $30-50 million minimum check sizes, >20% ownership targets, mandatory board seats, vetoes on M&A events, and multi-layered decision making. As such, the firm works collaboratively with Founders to craft the ideal financing that minimizes dilution, saves the company time and effort, while accommodating insider appetite and making room for strategics if relevant. Harmony has a longer-term orientation than most funds because the majority of its capital comes from seven billionaire family offices, and as result, the firm looks to buy in the IPO, not sell. Since 1993, the founding partners have invested in over 80 technology-driven companies including Anaplan, AppDynamics, Aveksa, ComScore, Coremetrics, E*Trade, Intersect ENT, Natera, Predictive Systems, Postmates, Priceline, Peribit, Scopus, Spotify, SS&C, Xactly, and Zerto. To learn more, please visit www.harmonyvp.com.

Suppliers
Hovione Farmaciência SA Wholesale: Consumer Non-Durables/Sundries | Loures, Portugal

Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Medtronic Plc Medical Products & Equipment - Dublin, Irl

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker Corporation Medical Products & Equipment - Kalamazoo, Michigan

Stryker is one of the world’s leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives.

Awards & Honors
Rank #39
2014
Forbes - America's Most Promising Companies
Sponsored by Forbes Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Intersect ENT, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Intersect ENT, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Intersect ENT, Inc..